Indivior Pharmaceuticals reported total assets of $1233.00M and total liabilities of $1441.00M for the quarter ended Jun 2026, down 15.1% year over year. This balance sheet covers 13 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2021 | Dec2022 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash & EquivalentsCash & Equiv. | 1,102.00M | 774.00M | 316.00M | 319.00M | 372.00M | 510.00M | 445.00M | 195.00M | 175.00M | 222.00M | |||
| Short-term InvestmentsInvestments (Current) | 119.00M | 94.00M | 1.00M | 1.00M | |||||||||
| Cash & Current Investments | 1,102.00M | 893.00M | 410.00M | 320.00M | 373.00M | 510.00M | 445.00M | 195.00M | 175.00M | 222.00M | |||
| Receivables - NetNet Receivables | 202.00M | 220.00M | 254.00M | 254.00M | 243.00M | 240.00M | 259.00M | 253.00M | 273.00M | 271.00M | |||
| Receivables - OtherOther Receivables | 1.00M | 2.00M | 2.00M | ||||||||||
| Receivables | 202.00M | 220.00M | 255.00M | 256.00M | 243.00M | 240.00M | 259.00M | 255.00M | 273.00M | 271.00M | |||
| Inventory | 95.00M | 114.00M | 126.00M | 167.00M | 163.00M | 149.00M | 155.00M | 153.00M | 152.00M | 150.00M | |||
| Prepaid Assets | 52.00M | 31.00M | 56.00M | 28.00M | 30.00M | 34.00M | 15.00M | 14.00M | |||||
| Current Assets | 1,444.00M | 1,259.00M | 1,257.00M | 827.00M | 883.00M | 951.00M | 922.00M | 652.00M | 667.00M | 725.00M | |||
| Non-Current Assets | |||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 58.00M | 54.00M | 84.00M | 100.00M | 104.00M | 117.00M | 124.00M | 144.00M | 157.00M | 162.00M | |||
| Long-Term Investments | 41.00M | 27.00M | 27.00M | 27.00M | 28.00M | 28.00M | 27.00M | 27.00M | |||||
| Goodwill | 5.00M | 2.00M | 2.00M | 2.00M | |||||||||
| Goodwill & Intangibles | 82.00M | 70.00M | 13.00M | 2.00M | 6.00M | 7.00M | 7.00M | 2.00M | 2.00M | 2.00M | 2.00M | ||
| Long-Term Deferred Tax | 105.00M | 219.00M | 286.00M | 277.00M | 279.00M | 270.00M | 285.00M | 323.00M | 296.00M | 271.00M | |||
| Other Non-Current Assets | 106.00M | 38.00M | 36.00M | 39.00M | 39.00M | 44.00M | 27.00M | 27.00M | 26.00M | 24.00M | |||
| Non-Current Assets | 501.00M | 489.00M | 492.00M | 501.00M | 494.00M | 549.00M | 530.00M | 508.00M | |||||
| Assets | 1,758.00M | 1,316.00M | 1,375.00M | 1,452.00M | 1,416.00M | 1,201.00M | 1,197.00M | 1,233.00M | |||||
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payables | 720.00M | 617.00M | 195.00M | 216.00M | 183.00M | 196.00M | 215.00M | 250.00M | 178.00M | 206.00M | |||
| Notes Payables | 3.00M | 3.00M | 3.00M | ||||||||||
| Payables | 723.00M | 620.00M | 198.00M | 216.00M | 183.00M | 196.00M | 215.00M | 250.00M | 178.00M | 206.00M | |||
| Other Accumulated Expenses | 492.00M | 99.00M | 105.00M | 105.00M | 106.00M | 42.00M | 14.00M | 14.00M | |||||
| Short term Debt | 3.00M | 18.00M | 18.00M | 18.00M | 18.00M | 29.00M | |||||||
| Current Taxes | 7.00M | 9.00M | 8.00M | 7.00M | 12.00M | 17.00M | 4.00M | 2.00M | 26.00M | 30.00M | |||
| Total Current Liabilities | 804.00M | 1,019.00M | 1,281.00M | 924.00M | 1,005.00M | 1,056.00M | 965.00M | 914.00M | 779.00M | 868.00M | |||
| Non-Current Liabilities | |||||||||||||
| Non-Current Debt | 239.00M | 237.00M | 237.00M | 315.00M | 311.00M | 308.00M | 304.00M | 290.00M | 486.00M | 487.00M | |||
| Operating Leases | 36.00M | 29.00M | 34.00M | 32.00M | 30.00M | 29.00M | 24.00M | 22.00M | 14.00M | 13.00M | |||
| Other Non-Current Liabilities | 474.00M | 428.00M | 359.00M | 365.00M | 297.00M | 299.00M | 300.00M | 52.00M | 41.00M | 42.00M | |||
| Total Non-Current Liabilities | 825.00M | 699.00M | 649.00M | 1,288.00M | 1,363.00M | 1,410.00M | 1,323.00M | 1,247.00M | 1,300.00M | 1,399.00M | |||
| Total Liabilities | 1,942.00M | 1,653.00M | 1,660.00M | 1,709.00M | 1,623.00M | 1,299.00M | 1,341.00M | 1,441.00M | |||||
| Shareholder's Equity | |||||||||||||
| Total Debt | 242.00M | 240.00M | 243.00M | 333.00M | 329.00M | 326.00M | 322.00M | 319.00M | 486.00M | 487.00M | |||
| Common Equity | 121.00M | -15.00M | -184.00M | -161.00M | -281.00M | -310.00M | -337.00M | -285.00M | -257.00M | -207.00M | -98.00M | -144.00M | -208.00M |
| Liabilities and Shareholders Equity | 1,758.00M | 1,316.00M | 1,375.00M | 1,452.00M | 1,416.00M | 1,201.00M | 1,197.00M | 1,233.00M | |||||
| Retained Earnings | 1,438.00M | 1,303.00M | -288.00M | -443.00M | -406.00M | -388.00M | -346.00M | -243.00M | -280.00M | -334.00M |
Pull Indivior Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=INDV&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "INDV", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=INDV&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();